Phyla is developing alternative therapies for antibiotics.
Phyla's investors include Willow Growth Partners, Squared Circles, Progression, Newchip Accelerator, Shiseido.
Phyla is headquartered in San Francisco, United States.
Phyla is developing alternative therapies for antibiotics.
Phyla is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phyla — Funding & Investors." VCBacked, December 7, 2023, https://www.vcbacked.co/company/phyla. Accessed October 30, 2026.
VCBacked. (2023). Phyla — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/phyla
{{cite web |title=Phyla — Funding & Investors |url=https://www.vcbacked.co/company/phyla |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated